1-8 of 8
Shaw Cheng Liu
Close
Sort by
Journal Articles

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity

Junli Yan, Siok-Bian Ng, Jim Liang-Seah Tay, Baohong Lin, Tze Loong Koh, Joy Tan, Viknesvaran Selvarajan, Shaw-Cheng Liu, Chonglei Bi, Shi Wang, Shoa-Nian Choo, Norio Shimizu, Gaofeng Huang, Qiang Yu, Wee-Joo Chng
Journal: Blood
Blood (2013) 121 (22): 4512–4520.
https://doi.org/10.1182/blood-2012-08-450494
Published: 2013
Includes: Supplemental data
Journal Articles

EZH2 Is Aberrantly Expressed and Plays a Pro-Proliferative Role Independent of Its Methyltransferase Activity in Natural Killer/T-Cell Lymphoma

Wee-Joo Chng, Assoc/Prof, Junli Yan, PhD, Siok-Bian NG, Jim Tay, Ph.D., Baohong Lin, BSc, Tze-Loong Koh, B.sc., Joy Tan, BSc, Viknesvaran Selvarajan, Shaw-Cheng Liu, B.sc., Chonglei Bi, B.sc., Gaofeng Huang, PhD, Qiang Yu, Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3498.
https://doi.org/10.1182/blood.V120.21.3498.3498
Published: 2012
Journal Articles

Plasma Membrane Proteomics Identifies Biomarkers Associated with T(4;14) Multiple Myeloma

Zhigang Xie, PhD, Jayantha Gunaratne, PhD, Lip Lee Cheong, Shaw Cheng Liu, Tze Loong Koh, Gaofeng Huang, PhD, Walter Blackstock, Wee-Joo Chng, Assoc/Prof
Journal: Blood
Blood (2012) 120 (21): 1314.
https://doi.org/10.1182/blood.V120.21.1314.1314
Published: 2012
Journal Articles

The Pro-Metastasis Tyrosine Phosphatase, PRL-3 ( PTP4A3 ), Is a Novel Target of BCR-ABL Signaling Involved in Human Chronic Myeloid Leukemia

Jianbiao Zhou, M.D., Ph.D., Lip-Lee Cheong, B.sc., Sylvia Mahara, B.sc., Shaw-Cheng Liu, B.sc., Phyllis SY Chong, B.sc., Chonglei Bi, B.sc., Tze-Loong Koh, B.sc., Kelly OK Ong, B.sc., Qi Zeng, Ph.D., Wee-Joo Chng, MRCP, MRCPath
Journal: Blood
Blood (2011) 118 (21): 2741.
https://doi.org/10.1182/blood.V118.21.2741.2741
Published: 2011
Journal Articles

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML

Jianbiao Zhou, Chonglei Bi, Lip-Lee Cheong, Sylvia Mahara, Shaw-Cheng Liu, Kian-Ghee Tay, Tze-Loong Koh, Qiang Yu, Wee-Joo Chng
Journal: Blood
Blood (2011) 118 (10): 2830–2839.
https://doi.org/10.1182/blood-2010-07-294827
Published: 2011
Includes: Supplemental data
Journal Articles

The Histone Methyltransferase Inhibitor, DZNep, Upregulates TXNIP, Increases ROS Production and Targets Leukemia Cells In AML

Jianbiao Zhou, M.D., Ph.D., Chonglei Bi, B.sc., Shaw-Cheng Liu, Kian-Ghee Tay, Lip-Lee Cheong, B.sc., Tze-Loong Koh, B.sc., Qiang Yu, Ph.D., Wee-Joo Chng, MRCP, MRCPath
Journal: Blood
Blood (2010) 116 (21): 4355.
https://doi.org/10.1182/blood.V116.21.4355.4355
Published: 2010
Journal Articles

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Shaw-Cheng Liu, Wee-Joo Chng, Kian-Ghee Tay, Lai-Fong Poon, Zhigang Xie, Senthilnathan Palaniyandi, Hanry Yu, Keith B. Glaser, Daniel H. Albert, Steven K. Davidsen, Chien-Shing Chen
Journal: Blood
Blood (2009) 113 (17): 4052–4062.
https://doi.org/10.1182/blood-2008-05-156422
Published: 2009
Includes: Supplemental data
Journal Articles

Identification of Core Gene Signature Associated with Synergism Between ABT-869, a FLT3 Inhibitor and SAHA, a HDAC Inhibitor in AML with FLT3-ITD Mutation.

Jianbiao Zhou, MD, MS, Chonglei Bi, Bsc, Shaw-Cheng Liu, Wee-Joo Chng, MD, Kian-Ghee Tay, Bsc, Hanry Yu, Ph.D., Keith Glaser, Ph.D., Daniel Albert, PhD, BSc, Steven K Davidsen, Ph.D., Chien-Shing Chen, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1618.
https://doi.org/10.1182/blood.V112.11.1618.1618
Published: 2008